Firas Zahr, Howard K Song, Scott Chadderdon, Hemal Gada, Mubashir Mumtaz, Timothy Byrne, Merick Kirshner, Samin Sharma, Susheel Kodali, Isaac George, William Merhi, Leora Yarboro, Paul Sorajja, Vinayak Bapat, Tanvir Bajwa, Eric Weiss, Jeremy J Thaden, Elizabeth Gearhart, Scott Lim, Michael Reardon, David Adams, Michael Mack, Martin B Leon
BACKGROUND: High surgical risk may preclude mitral valve replacement in many patients. Transcatheter Mitral Valve Replacement (TMVR) using transfemoral transseptal access is a novel technology for the treatment of mitral regurgitation (MR) in high-risk surgical patients. OBJECTIVE: This analysis evaluates 30-day and 1-year outcomes of the Intrepid TMVR Early Feasibility Study (EFS) in patients with ≥ moderate-severe MR. METHODS: The EFS is a multi-center, prospective, single-arm study...
October 10, 2023: JACC. Cardiovascular Interventions